In Situ Global Clinical Trials Network, LLC

USA

Cooperative of United States Board Certified Specialist and Subspecialist Physicians dedicated to improving Hispanic participation in Clinical Trials.

Shareable draft

Check out In Situ Global Clinical Trials Network, LLC on @MedStartr Today Cooperative of United States Board Certified Specialist and Subspecialist Physicians dedicated to improving Hispanic participation in Clinical Trials. #MedMo #MedStartrVentures

https://www.medstartr.ai/s/pk4VWmHEJdE

Get Involved in In Situ Global Clinical Trials Network, LLC

How We Help

Company Info

Clinical & IP

🔬

Clinical Validation

In Situ Global Clinical Trials Network, LLC is strictly limited to the conduction of clinical trials, the clinical testing whose results are utilized to determine the clinical efficacy of biomedical products, as defined by the United States of America National Institutes of Health (<a href="https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-015.html" target="_blank">https://grants.nih.gov/grants/guide/notice-files/NOT-OD-15-015.html</a>). In Situ Global Clinical Trials Network, LLC does not develop biomedical products itself, but collaborates with a wide array of sponsors to provide objective, unbiased clinical information, as per United States of America Food and Drug Administration (FDA) and Institutional Review Boards (IRB)-approved clinical trial protocols, to determine the efficacy of a biomedical product.

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of In Situ Global Clinical Trials Network, LLC?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.

Get Involved in In Situ Global Clinical Trials Network, LLC